Font: Financial Modeling Prep • Oct 19, 2026
Northrop Grumman (NYSE: NOC) is expected to report third-quarter earnings before the market opens on October 20, 2026. The defense contractor builds military aircraft, missiles, and space systems. Wall Street estimates earnings of $7.18 per share and revenue of about $11.10 billion.
Estimates vary by source. As highlighted by Zacks Investment Research, analysts expect earnings of $7.22 per share for the quarter ended September 2026, down 5.9% from a year earlier. They forecast revenue of $11.06 billion, up 6.1%. Zacks also reports that its consensus earnings estimate has risen 0.4% over the past 30 days.
Higher revenue alongside lower earnings would mean Northrop Grumman makes less profit per share despite bringing in more sales. Increased B-21 Raider production, weapons demand, and work on the Sentinel program could support sales, as highlighted by Zacks Investment Research. Northrop Grumman’s 2026 sales guidance is $43.75 billion to $44.25 billion, though Sentinel costs and execution remain risks.
Northrop Grumman also received an $18.80 million U.S. Army contract on September 29 to develop propulsion technology for XRC missile prototypes, as highlighted by Benzinga. The contract adds to its defense work, but its value is small compared with the roughly $11.10 billion in quarterly revenue Wall Street expects.
|
SHFS§>
SHF Holdings, Inc.
|
$0.02
-27.39%
|
|
FRTT§>
Fort Technology Inc.
|
$0.60
56.84%
|
|
YFOR§>
YYForce Inc.
|
$0.03
-32.73%
|
|
LICN§>
Lichen International Limited
|
$0.02
-16.67%
|
|
NVDA§>
NVIDIA Corporation
|
$153.17
-1.90%
|
|
SMTK§>
SmartKem, Inc.
|
$0.25
54.67%
|
|
SOXL§>
Direxion Daily Semiconductor Bull 3X ETF
|
$46.89
-3.84%
|
|
SPDN§>
Direxion Daily S&P 500 Bear 1X ETF
|
$8.90
1.19%
|
|
SLS§>
SELLAS Life Sciences Group, Inc.
|
$19.50
161.04%
|
|
GP§>
GreenPower Motor Company Inc.
|
$2.43
72.34%
|